Is there an element of the Theranos strategic audit (internal and/or external analysis) that points to the strength or weakness of the underlying business model?

Review the Theranos case study materials and respond to the following prompts. Make sure to support your responses with relevant textbook concepts from previous chapters and recent chapters 4 & 5.

1) Is there an element of the Theranos strategic audit (internal and/or external analysis) that points to the strength or weakness of the underlying business model?

2) In your opinion, is there a juncture

in the Theranos strategic trajectory when management and/or stakeholder changes might have altered the company’s future?

Theranos Links:
https://www.proquest.com/docview/2616423368?accountid=14573&parentSessionId=TBYEqc0hDRuhZmq6hhxyiulrSb6TuYBb00SfYgaexUA%3D&forcedol=true

https://www.kanopy.com/en/product/5762253?vp=umassd

Last Completed Projects

topic title academic level Writer delivered